Inventor · disambiguated record
Peter Scholz
Also filed as: SCHOLZ PETER
9 granted patents·3 pending applications·45 citations·filing 1992–2015
86Inventor score
Top patents by PatentIndex Score
12 records- 0185US8399627B2Antibodies to TNFαVOTSMEIER CHRISTIAN·Filed 2008·Granted Mar 19, 2013·17 cites·12 claims
- 0284US8481030B2Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)WANG ZHUOZHI·Filed 2011·Granted Jul 9, 2013·12 cites·6 claims
- 0373US9309324B2Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)WANG ZHUOZHI·Filed 2011·Granted Apr 12, 2016·3 cites·10 claims
- 0468US9534046B2Antibodies to TNFαBAYER IP GMBH·Filed 2015·Granted Jan 3, 2017·1 cites·18 claims
- 0552US2008160558A1Process for generating sequence-specified proteases by directed evolution and use thereofDIREVO BIOTECH AG·Filed 2007·Application pending·0 cites
- 0649USRE47150EOptimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)BAYER HEALTHCARE LLC·Filed 2011·Granted Dec 4, 2018·0 cites·24 claims
- 0748US2013230886A1Antibodies to TNF AlphaVOTSMEIER CHRISTIAN·Filed 2013·Application pending·0 cites
- 0845US2004072276A1Process for generating sequence-specific proteases by directed evolution and use thereofDIREVO BIOTECH AG·Filed 2003·Application pending·0 cites
- 0942US5624670AUse of interleukin-8 for inducing cervical ripeningMEDICAL RES COUNCIL·Filed 1992·Granted Apr 29, 1997·6 cites·22 claims
- 1039US6114510AProcess for the purification of recombinant human interleukin-8SCHERING AG·Filed 1996·Granted Sep 5, 2000·3 cites·36 claims
- 1131US5654339AUse of prostane derivatives of formulate I and II for treatment of chronic polyarthritisSCHERING AG·Filed 1993·Granted Aug 5, 1997·2 cites·17 claims
- 1226US6040336AProstane derivatives and the combination thereof with antibiotics in the treatment of bacterial infectionsSCHERING AG·Filed 1996·Granted Mar 21, 2000·1 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Peter Scholz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →